Annual EBIT
-$114.17 M
-$3.10 M-2.79%
31 December 2023
Summary:
Tango Therapeutics annual earnings before interest & taxes is currently -$114.17 million, with the most recent change of -$3.10 million (-2.79%) on 31 December 2023. During the last 3 years, it has fallen by -$61.97 million (-118.72%). TNGX annual EBIT is now -118.72% below its all-time high of -$51.48 million.TNGX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$32.88 M
-$3.33 M-11.25%
30 September 2024
Summary:
Tango Therapeutics quarterly earnings before interest & taxes is currently -$32.88 million, with the most recent change of -$3.33 million (-11.25%) on 30 September 2024. Over the past year, it has dropped by -$7.25 million (-28.30%). TNGX quarterly EBIT is now -621.64% below its all-time high of -$4.56 million, reached on 30 June 2021.TNGX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$139.70 M
-$7.25 M-5.48%
30 September 2024
Summary:
Tango Therapeutics TTM earnings before interest & taxes is currently -$139.70 million, with the most recent change of -$7.25 million (-5.48%) on 30 September 2024. Over the past year, it has dropped by -$29.97 million (-27.32%). TNGX TTM EBIT is now -422.20% below its all-time high of -$26.75 million, reached on 30 September 2020.TNGX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.8% | -28.3% | -27.3% |
| 3 y3 years | -118.7% | -68.0% | -209.5% |
| 5 y5 years | - | - | - |
TNGX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -118.7% | at low | -68.0% | +22.2% | -209.5% | at low |
| 5 y | 5 years | -118.7% | at low | -621.6% | +22.2% | -422.2% | at low |
| alltime | all time | -118.7% | at low | -621.6% | +22.2% | -422.2% | at low |
Tango Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$32.88 M(+11.3%) | -$139.70 M(+5.5%) |
| June 2024 | - | -$29.55 M(-30.1%) | -$132.45 M(+5.0%) |
| Mar 2024 | - | -$42.26 M(+20.7%) | -$126.14 M(+10.5%) |
| Dec 2023 | -$114.17 M(+2.8%) | -$35.01 M(+36.6%) | -$114.17 M(+4.1%) |
| Sept 2023 | - | -$25.63 M(+10.2%) | -$109.73 M(-3.8%) |
| June 2023 | - | -$23.25 M(-23.2%) | -$114.02 M(-1.7%) |
| Mar 2023 | - | -$30.29 M(-0.9%) | -$115.98 M(+4.4%) |
| Dec 2022 | -$111.07 M | -$30.57 M(+2.2%) | -$111.07 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$29.92 M(+18.7%) | -$102.49 M(+11.2%) |
| June 2022 | - | -$25.20 M(-0.7%) | -$92.13 M(+28.9%) |
| Mar 2022 | - | -$25.38 M(+15.4%) | -$71.49 M(+22.9%) |
| Dec 2021 | -$58.19 M(+11.5%) | -$21.98 M(+12.3%) | -$58.19 M(+28.9%) |
| Sept 2021 | - | -$19.57 M(+329.5%) | -$45.14 M(-13.7%) |
| June 2021 | - | -$4.56 M(-62.3%) | -$52.33 M(+9.5%) |
| Mar 2021 | - | -$12.08 M(+35.2%) | -$47.77 M(+33.9%) |
| Dec 2020 | -$52.20 M | -$8.94 M(-66.6%) | -$35.69 M(+33.4%) |
| Sept 2020 | - | -$26.75 M | -$26.75 M |
FAQ
- What is Tango Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Tango Therapeutics?
- What is Tango Therapeutics annual EBIT year-on-year change?
- What is Tango Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Tango Therapeutics?
- What is Tango Therapeutics quarterly EBIT year-on-year change?
- What is Tango Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Tango Therapeutics?
- What is Tango Therapeutics TTM EBIT year-on-year change?
What is Tango Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TNGX is -$114.17 M
What is the all time high annual EBIT for Tango Therapeutics?
Tango Therapeutics all-time high annual earnings before interest & taxes is -$51.48 M
What is Tango Therapeutics annual EBIT year-on-year change?
Over the past year, TNGX annual earnings before interest & taxes has changed by -$3.10 M (-2.79%)
What is Tango Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TNGX is -$32.88 M
What is the all time high quarterly EBIT for Tango Therapeutics?
Tango Therapeutics all-time high quarterly earnings before interest & taxes is -$4.56 M
What is Tango Therapeutics quarterly EBIT year-on-year change?
Over the past year, TNGX quarterly earnings before interest & taxes has changed by -$7.25 M (-28.30%)
What is Tango Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TNGX is -$139.70 M
What is the all time high TTM EBIT for Tango Therapeutics?
Tango Therapeutics all-time high TTM earnings before interest & taxes is -$26.75 M
What is Tango Therapeutics TTM EBIT year-on-year change?
Over the past year, TNGX TTM earnings before interest & taxes has changed by -$29.97 M (-27.32%)